Decision Points-Targeted Therapy for Metastatic Colorectal Cancer (mCRC): Addressing Practical Challenges
WebcastFaculty
OVERVIEW
Decision Points-Targeted Therapy for Metastatic Colorectal Cancer (mCRC): Addressing Practical Challenges is organized by prIME Oncology and will be held during Oct 13, 2017 - Oct 13, 2018.
The target audience for this medical event is medical oncologists, gastroenterologists, radiation and surgical oncologists, and other healthcare professionals involved in the management of patients with metastatic colorectal cancer. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits
Hear from the experts on the optimal use of targeted therapy for metastatic colorectal cancer (mCRC). Practical challenges like treatment sequence, third-line therapy, and management of high microsatellite instability (MSI-H) will be discussed. A clinical scenario with patient history, laboratory results, and options for next steps in treatment provide commentary and insight for decision making in the care of your patients with mCRC.
Conference Objectives are :
After successful completion of this educational activity, participants should be able to:
• Describe findings from recent clinical trials that can help determine an appropriate treatment sequence based on individual patient and disease characteristics
• Distinguish the adverse event profiles associated with treatment options for relapsed mCRC, as well as dose adjustment strategies for management of treatment-related complications
• Select an appropriate dose of therapy for patients with mCRC
Additional details will be posted as soon as they are available.
The target audience for this medical event is medical oncologists, gastroenterologists, radiation and surgical oncologists, and other healthcare professionals involved in the management of patients with metastatic colorectal cancer. This CME Conference has been approved for a maximum of 0.75 AMA PRA Category 1 Credits
Hear from the experts on the optimal use of targeted therapy for metastatic colorectal cancer (mCRC). Practical challenges like treatment sequence, third-line therapy, and management of high microsatellite instability (MSI-H) will be discussed. A clinical scenario with patient history, laboratory results, and options for next steps in treatment provide commentary and insight for decision making in the care of your patients with mCRC.
Conference Objectives are :
After successful completion of this educational activity, participants should be able to:
• Describe findings from recent clinical trials that can help determine an appropriate treatment sequence based on individual patient and disease characteristics
• Distinguish the adverse event profiles associated with treatment options for relapsed mCRC, as well as dose adjustment strategies for management of treatment-related complications
• Select an appropriate dose of therapy for patients with mCRC
Additional details will be posted as soon as they are available.
SPECIALITIES
Oncology
Quick Links